NIMC
TEVA icon

NWQ Investment Management Company’s Teva Pharmaceuticals TEVA Stock Holding History

NWQ Investment Management Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-41,600
Closed -$1.04M – 159
2016
Q1 		$1.04M Buy
+41,600
New +$2.44M 0.02% 142

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

NWQ Investment Management Company's TEVA Position: Q2 2018 in Review

NWQ Investment Management Company sold out of Teva Pharmaceuticals (TEVA) in Q2 2018, closing a stake of 178,402 shares — an estimated $3.05M sold.

NWQ Investment Management Company first reported a position in TEVA in Q2 2013 and held it in 20 quarters. The position peaked at $333M in Q1 2014. 540 funds tracked by Wall St. Rank hold TEVA as of Q2 2018.

  • NWQ Investment Management Company reported no remaining Teva Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • NWQ Investment Management Company sold 178,402 Teva Pharmaceuticals shares in Q2 2018, an estimated $3.05M.
  • NWQ Investment Management Company first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • NWQ Investment Management Company's Teva Pharmaceuticals position peaked at $333M in Q1 2014.
  • 540 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2018.

Based on NWQ Investment Management Company's 13F filing for Q2 2018, filed 14 Aug 2018.